Other Assets, Noncurrent in USD of Spyre Therapeutics, Inc. from Q4 2015 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Spyre Therapeutics, Inc. quarterly Other Assets, Noncurrent history and change rate from Q4 2015 to Q3 2025.
  • Spyre Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending 30 Sep 2025 was $0.000, a 100% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Change (%)

Spyre Therapeutics, Inc. Quarterly Other Assets, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $0 -$10K -100% 30 Sep 2025 10-Q 04 Nov 2025
Q2 2025 $0 -$10K -100% 30 Jun 2025 10-Q 05 Aug 2025
Q1 2025 $10K $0 0% 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $10K +$1K +11.1% 31 Dec 2024 10-Q 04 Nov 2025
Q3 2024 $10K +$1K +11.1% 30 Sep 2024 10-Q/A 18 Nov 2024
Q2 2024 $10K $0 0% 30 Jun 2024 10-Q/A 18 Nov 2024
Q1 2024 $10K -$68K -87.2% 31 Mar 2024 10-Q/A 18 Nov 2024
Q4 2023 $9K -$674K -98.7% 31 Dec 2023 10-K 27 Feb 2025
Q3 2023 $9K -$740K -98.8% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $10K -$742K -98.7% 30 Jun 2023 10-Q 11 Aug 2023
Q1 2023 $78K -$722K -90.3% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $683K -$159K -18.9% 31 Dec 2022 10-K/A 18 Nov 2024
Q3 2022 $749K -$148K -16.5% 30 Sep 2022 10-Q 03 Nov 2022
Q2 2022 $752K -$796K -51.4% 30 Jun 2022 10-Q 04 Aug 2022
Q1 2022 $800K +$84K +11.7% 31 Mar 2022 10-Q 05 May 2022
Q4 2021 $842K +$727K +632% 31 Dec 2021 10-K 02 Mar 2023
Q3 2021 $897K +$775K +635% 30 Sep 2021 10-Q 04 Nov 2021
Q2 2021 $1.55M +$1.46M +1583% 30 Jun 2021 10-Q 05 Aug 2021
Q1 2021 $716K +$656K +1093% 31 Mar 2021 10-Q 10 May 2021
Q4 2020 $115K +$48K +71.6% 31 Dec 2020 10-K 08 Mar 2022
Q3 2020 $122K +$8K +7.02% 30 Sep 2020 10-Q 05 Nov 2020
Q2 2020 $92K -$28K -23.3% 30 Jun 2020 10-Q 10 Aug 2020
Q1 2020 $60K -$689K -92% 31 Mar 2020 10-Q 07 May 2020
Q4 2019 $67K +$17K +34% 31 Dec 2019 10-K 18 Mar 2021
Q3 2019 $114K +$65K +133% 30 Sep 2019 10-Q 06 Nov 2019
Q2 2019 $120K +$71K +145% 30 Jun 2019 10-Q 06 Aug 2019
Q1 2019 $749K +$616K +463% 31 Mar 2019 10-Q 07 May 2019
Q4 2018 $50K -$182K -78.4% 31 Dec 2018 10-K 24 Feb 2020
Q3 2018 $49K -$90K -64.7% 30 Sep 2018 10-Q 08 Nov 2018
Q2 2018 $49K -$90K -64.7% 30 Jun 2018 10-Q 09 Aug 2018
Q1 2018 $133K -$7K -5% 31 Mar 2018 10-Q 08 May 2018
Q4 2017 $232K +$192K +480% 31 Dec 2017 10-K 07 Mar 2019
Q3 2017 $139K +$99K +248% 30 Sep 2017 10-Q 07 Nov 2017
Q2 2017 $139K +$121K +672% 30 Jun 2017 10-Q 09 Aug 2017
Q1 2017 $140K +$122K +678% 31 Mar 2017 10-Q 09 May 2017
Q4 2016 $40K +$20K +100% 31 Dec 2016 10-K 13 Mar 2018
Q3 2016 $40K 30 Sep 2016 10-Q 09 Nov 2016
Q2 2016 $18K 30 Jun 2016 10-Q 09 Aug 2016
Q1 2016 $18K 31 Mar 2016 10-Q 19 May 2016
Q4 2015 $20K 31 Dec 2015 10-K 23 Mar 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.